SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $158,379,902 |
| Positions | 32 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| COGENT BIOSCIENCES INC | COGT | COM | $13,285,091 | 343,284 |
| AXSOME THERAPEUTICS INC. | AXSM | COM | $13,197,019 | 53,916 |
| GENMAB A/S | GMAB | SPONSORED ADS | $11,828,582 | 430,600 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | COM NEW | $10,700,963 | 287,583 |
| TREVI THERAPEUTICS INC | TRVI | COM | $9,776,778 | 524,224 |
| REVOLUTION MEDICINES INC | RVMD | COM | $9,561,206 | 51,053 |
| DEFINIUM THERAPEUTICS INC | DFTX | COM SHS | $8,856,785 | 188,282 |
| VIR BIOTECHNOLOGY INC | VIR | COM | $8,699,050 | 853,685 |
| IMMUNOVANT INC | IMVT | COM | $8,028,419 | 208,368 |
| UROGEN PHARMA LTD | URGN | COM | $7,040,318 | 191,313 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.